FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4491111000001108: Bextra 10mg tablets (Pfizer Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26533301000001118 Bextra 10mg tablets (Pfizer Ltd) 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
26533401000001114 Bextra 10mg tablets (Pfizer Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Is a Valdecoxib 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Is pack of Bextra 10mg tablets (Pfizer Ltd) false Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has active ingredient Valdecoxib false Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has AMP Bextra 10mg tablets (Pfizer Ltd) true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has specific active ingredient Valdecoxib true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bextra 10mg tablets (Pfizer Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start